Cristiana Seroto¹, Teresa Sequeira^1-3, Maria Inês Guimarães^1-4, Filipe Castro¹, Inês Lopes Cardoso^1-3 and Augusta Silveira^1-4*

¹FCS-UFP, Faculdade de Ciências da Saúde, Universidade Fernando Pessoa, Porto, Portugal
²FP-I3ID, Instituto de Investigação, Inovação e Desenvolvimento, FP-BHS, Biomedical and Health Sciences, Universidade Fernando Pessoa, Porto, Portugal
³Centro de Investigação em Tecnologias e Serviços de Saúde, Rede de Investigação em Saúde, Universidade Fernando Pessoa, Porto, Portugal
⁴Author’s Department, University, Country CEISUC/CIBB

*Corresponding Author: Augusta Silveira, FCS-UFP, Faculdade de Ciências da Saúde, Universidade Fernando Pessoa, Porto, Portugal.

Received: January 20, 2025; Published: January 31, 2025

Abstract

Oncological pathology of the oral cavity is a subject of study due to its significant impact on the quality of life of patients, caregivers and on public health. According to the National Institute of Statistics, oncological disease is the second leading cause of death in Portugal, with oral and pharyngeal cancer having an incidence rate of 16.7% and a 50% mortality rate. Periodontal disease is one of the most prevalent infectious conditions in the world, affecting 25-40% of the adult population. This pathology is often associated with the presence of Porphyromonas gingivalis and Fusobacterium nucleatum, being a consequence of the complex interactions between these microorganisms and their products, triggering a host inflammatory response that leads to tissue destruction, increasingly associated with oral oncogenesis and tumor progression.
This work goal is to study the involvement of Porphyromonas gingivalis and Fusobacterium nucleatum in oral oncogenesis and tumor progression to understand how these bacteria influence the pathophysiology of oral cavity cancer.
The conducted systematic review used Cochrane guidelines through the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) diagram and based on the Population, Intervention, Comparison, Outcome (PICO) criteria. Literature search covered four databases – B On, Science Direct, PubMed, Cochrane Library - and grey literature (master's theses, conference proceedings, world organizations). Publications between 2013 and 2023 were selected for full reading.
Several mechanisms explain the association between Porphyromonas gingivalis and Fusobacterium nucleatum and oral oncogenesis and tumor progression. These bacteria can promote cell proliferation by modulating various signaling pathways, and facilitate cellular invasion, allowing the dissemination of cancer cells. Another important mechanism is the induction of chronic inflammation. Prolonged inflammatory response creates a favorable environment for tumor progression. Pro-inflammatory cytokines (interleukin-6 and interleukin-8) play key roles in the inflammatory process, promoting cell proliferation, invasion, and metastasis. Immune evasion is the mechanism by which cancer cells avoid detection and destruction by the immune system. These bacterial strains modulate host immune response, favoring survival and dissemination of cancer cells. This systematic review highlights the complex interaction between chronic inflammation induced by periodontal bacteria and oral oncogenesis. The results underline the need for future investigations to deepen the molecular mechanisms involved and to develop effective therapeutic approaches. Early identification and targeted treatment of chronic inflammation, as well as modulation of the oral microbiome, may be promising strategies to improve clinical outcomes for oral cancer patients, highlighting the importance of preventive measures in oral oncology.

Keywords: "Porphyromonas Gingivalis"; "Fusobacterium Nucleatum"; "Periodontal Disease"; "Oral Microbiome"; "Oral Oncogenesis"; "Risk Factors"

References

1. Global Cancer Observatory. “Lip, Oral Cavity” Fact Sheet (2020a).
2. Giraldi L., et al. “Infection with Human Papilloma Virus (HPV) and risk of subsites within the Oral Cancer”. Cancer Epidemiology 75 (2021): 102020.
3. Farthing PM and Speight PM. “Educational aspects of Oral Cancer”. British Dental Journal9 (2018): 875-878.
4. Johnson DE., et al. “Head and Neck Squamous Cell Carcinoma”. Nature Reviews Disease Primers1 (2020): 92.
5. Du M., et al. “Incidence trends of lip, oral cavity, and pharyngeal cancers: Global Burden of Disease 1990-2017”. Journal of Dental Research2 (2020): 143-151.
6. Global Cancer Observatory. Portugal Fact Sheet (2020b).
7. Ghalwash DM. “Diagnostic and prognostic value of salivary biomarkers in oral cancer and precancer”. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology6 (2020): 538-543.
8. Abati S., et al. “Oral Cancer and Precancer: A narrative review on the relevance of early diagnosis”. International Journal of Environmental Research and Public Health24 (2020): 9160.
9. Chen Q., et al. “Salivary Porphyromonas gingivalis predicts outcome in oral squamous cell carcinomas: A cohort study”. BMC Oral Health1 (2021): 228.
10. Gasparoni LM., et al. “Periodontitis as a risk factor for head and neck cancer”. Medicina Oral, Patologia Oral y Cirurgia Bucal4 (2021): e430-e436.
11. Wang B., et al. “The roles and interactions of Porphyromonas gingivalis and Fusobacterium nucleatum in oral and gastrointestinal carcinogenesis: A narrative review”. Pathogens 1 (2024): 93.
12. Sukmana BI., et al. “Oral microbiota and Oral Squamous Cell Carcinoma: A review of their relation and carcinogenic mechanisms. Frontiers in Oncology 14 (2024): 1319777.
13. Fitzsimonds ZR., et al. “From beyond the pale to the pale riders: The emerging association of bacteria with oral cancer”. Journal of Dental Research6 (2020): 604-612.
14. Kumari P., et al. “Oral potentially malignant disorders: Etiology, pathogenesis, and transformation into oral cancer”. Frontiers in Pharmacology 13 (2022): 825266.
15. Chang C., et al. “The prevalence rate of periodontal pathogens and its association with Oral Squamous Cell Carcinoma”. Applied Microbiology and Biotechnology3 (2019): 1393-1404.
16. Olsen I and Yilmaz Ö. “Possible role of Porphyromonas gingivalis in orodigestive cancers”. Journal of Oral Microbiology 11 (2019):
17. Li Q., et al. “Role of oral bacteria in the development of oral squamous cell carcinoma”. Cancers 12 (2020): 2797.
18. Mei F., et al. “Porphyromonas gingivalis and its systemic impact: Current status”. Pathogens11 (2020): 944.
19. Zhang L., et al. “The oral microbiota may have influence on oral cancer”. Frontiers in Cellular and Infection Microbiology 9 (2020): 476.
20. Ameena M and Rathy R. “Evaluation of tumor necrosis factor: Alpha in the saliva of oral cancer, leukoplakia, and healthy controls-A comparative study”. Journal of International Oral Health2 (2019): 92.
21. Karpiński TM. “Role of oral microbiota in cancer development”. Microorganisms1 (2019): 20.
22. Chattopadhyay I., et al. “Role of oral microbiome signatures in diagnosis and prognosis of oral cancer”. Technology in Cancer Research and Treatment 18 (2019): 1533033819867354.
23. Inaba H., et al. “Porphyromonas gingivalis promotes invasion of Oral Squamous Cell Carcinoma through induction of proMMP9 and its activation”. Cellular Microbiology1 (2014): 131-145.
24. Ha NH., et al. “Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs”. Cytokine 85 (2016): 155-163.
25. Choi S., et al. “The effect of surface material, roughness and wettability on the adhesion and proliferation of Streptococcus gordonii, Fusobacterium nucleatum and Porphyromonas gingivalis”. Journal of Dental Sciences 18 (2023): 517-525.
26. Alotaibi GF and Bukhari MA. “Factors influencing bacterial biofilm formation and development”. American Journal of Biomedical Sciences Research6 (2021): 617-626.
27. McIlvanna E., et al. “Fusobacterium nucleatum and Oral Cancer: A critical review”. BMC Cancer 21 (2021): 1212.
28. Ma Y., et al. “Potential role of epithelial-mesenchymal transition induced by periodontal pathogens in oral cancer”. Journal of Cellular and Molecular Medicine1 (2024): e18064.
29. Pignatelli P., et al. “The role of Fusobacterium nucleatum in oral and colorectal carcinogenesis”. Microorganisms 11 (2023): 2358.
30. Perera M., et al. “Inflammatory bacteriome and oral squamous cell carcinoma”. Journal of Dental Research 97 (2018): 725-732.
31. Fujiwara N., et al. “Involvement of Fusobacterium Species in oral cancer progression: A literature review including other types of cancer”. International Journal of Molecular Sciences17 (2020): 6207.
32. Bui F.Q., et al. “Fusobacterium nucleatum infection of gingival epithelial cells leads to NLRP3 inflammasome-dependent secretion of IL-1β and the danger signals ASC and HMGB1”. Cellular Microbiology7 (2016): 970-981.
33. Geng F., et al. “Fusobacterium nucleatum caused DNA damage and promoted cell proliferation by the Ku70/p53 pathway in oral cancer cells”. DNA and Cell Biology1 (2020): 144-151.
34. Marques J.F., et al. “Revisões Sistemáticas: O que são e para que servem”. Revista Portuguesa de Estomatologia, Medicina Dentária e Cirurgia Maxilofacial3 (2008): 171-178.
35. Page M.J., et al. “PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews”. BMJ 372 (2021): 71.
36. Santos C.M.C., et al. “A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências”. Revista Latino-Americana de Enfermagem3 (2007): 508-511.
37. Sheth V.H., et al. “Development and validation of a Risk-of-Bias tool for assessing in vitro studies conducted in dentistry: The QUIN”. The Journal of Prosthetic Dentistry 6 (2022): 1038-1042.
38. Cho T.J., et al. “Porphyromonas gingivalis-induced autophagy suppresses cell proliferation through G1 arrest in oral cancer cells”. Archives of Oral Biology4 (2014): 370-378.
39. Inaba H., et al. “Involvement of protease-activated receptor 4 in over-expression of matrix metalloproteinase 9 induced by Porphyromonas gingivalis”. Medical Microbiology and Immunology5 (2015): 605-612.
40. Ha N.H., et al. “Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties”. Tumor Biology12 (2015): 9947-9960.
41. Inaba H., et al. “Apple- and hop-polyphenols inhibit Porphyromonas gingivalis-mediated precursor of matrix metalloproteinase-9 activation and invasion of Oral Squamous Cell Carcinoma cells”. Journal of Periodontology9 (2016): 1103-1111.
42. Cho B.H., et al. “Acetylshikonin suppresses invasion of Porphyromonas gingivalis-infected YD10B oral cancer cells by modulating the interleukin-8/matrix metalloproteinase axis”. Molecular Medicine Reports2 (2018): 2327-2334.
43. Geng F., et al. “Persistent exposure to Porphyromonas gingivalis promotes proliferative and invasion capabilities, and tumorigenic properties of human immortalized oral epithelial cells”. Frontiers in Cellular and Infection Microbiology 7 (2017): 57.
44. Groeger S., et al. “Porphyromonas gingivalis activates NFκB and MAPK pathways in human oral epithelial cells”. BMC Immunology1 (2017): 1.
45. Shao W., et al. “Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells”. Scientific Reports 11 (2021): 14943.
46. Park D.-G., et al. “Serum levels of interleukin-6 and titers of antibodies against Porphyromonas gingivalis could be potential biomarkers for the diagnosis of Oral Squamous Cell Carcinoma”. International Journal of Molecular Sciences11 (2019): 2749.
47. Tanaka T and Narazaki M. “IL-6 and related cytokines as the critical regulators of chronic inflammatory diseases”. Cytokine Growth Factor Reviews 50 (2020): 1-10.
48. Waugh DJJ and Wilson C. “The interleukin-8 pathway in cancer”. Clinical Cancer Research21 (2008): 6735-6741.
49. Huynh J., et al. “Porphyromonas gingivalis exposure induces an interleukin-6 receptor-mediated inflammatory signaling cascade in human oral epithelial cells”. Molecular Oral Microbiology2 (2016): 93-105.

Citation

Citation: Augusta Silveira., et al. “Porphyromonas Gingivalis and Fusobacterium nucleatum in oral Oncogenesis and Tumour Progression".Acta Scientific Microbiology 8.2 (2025): 106-120.

Copyright

Copyright: © 2025 Joshi Chinmay., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.